Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009–2014
暂无分享,去创建一个
B. Rasmussen | S. Hansen | R. Laursen | M. Kosteljanetz | H. Schultz | B. Nørgård | R. Guldberg | K. Gradel | Rikke Guldberg
[1] E. McFadden,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.
[2] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[3] N. Laperriere,et al. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] J. Jääskeläinen,et al. Debulking or biopsy of malignant glioma in elderly people – a randomised study , 2003, Acta Neurochirurgica.
[5] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[6] C. Menichelli,et al. Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers. , 2006, International journal of radiation oncology, biology, physics.
[7] K. Aldape,et al. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. , 2006, Neuro-oncology.
[8] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[9] H. Heinzl,et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry , 2009, Journal of Neuro-Oncology.
[10] R. Stendel. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. , 2009, Neurosurgery.
[11] H. Duffau,et al. French Brain Tumor DataBase: 5‐Year Histological Results on 25 756 Cases , 2011, Brain pathology.
[12] Mitchel S Berger,et al. An extent of resection threshold for newly diagnosed glioblastomas. , 2011, Journal of neurosurgery.
[13] E. Helseth,et al. A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme. , 2012, Neuro-oncology.
[14] Didier Frappaz,et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. , 2012, The Lancet. Oncology.
[15] G. Reifenberger,et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. , 2012, The Lancet. Oncology.
[16] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[17] Henrik Toft Sørensen,et al. The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.
[18] Reid C. Thompson,et al. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme , 2014, Journal of Neuro-Oncology.
[19] A. Brodbelt,et al. Glioblastoma in England: 2007-2011. , 2015, European journal of cancer.
[20] R. Henriksson,et al. Brain tumors in Sweden: Data from a population-based registry 1999–2012 , 2015, Acta oncologica.
[21] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[22] H. Duffau,et al. Epidemiology for primary brain tumors: a nationwide population-based study , 2017, Journal of Neuro-Oncology.
[23] S. Hansen. The Danish Neuro-Oncology Registry , 2012, Clinical epidemiology.
[24] Dima Suki,et al. Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. , 2016, JAMA oncology.
[25] Matthew Koshy,et al. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis. , 2016, JAMA neurology.
[26] B. Rasmussen,et al. The Danish Neuro-Oncology Registry: establishment, completeness and validity , 2016, BMC Research Notes.
[27] D. Osoba,et al. Short‐Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma , 2017, The New England journal of medicine.
[28] B. Rasmussen,et al. Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I–IV in the the Danish Neuro-Oncology Registry , 2017, Journal of Neuro-Oncology.
[29] Jill S Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014 , 2017, Neuro-oncology.